GRAIL Updates - GRAIL

svg figure

svg figure mobile

GRAIL Updates

Content

The NHS-Galleri trial: What to expect in 2026 from the world’s first randomized controlled trial of a Multi-Cancer Early Detection test, Galleri®

PATHFINDER 2: What to Expect from the Largest U.S. Multi-Cancer Early Detection (MCED) Interventional Trial

Making Sense of the Numbers: Interpreting Multi-Cancer Early Detection Test Performance

Not All MCED Tests are Created Equal: The Realities of MCED Test Development and Validation

GRAIL applauds policymakers’ commitment to MCED access

GRAIL Sponsored Industry Theater at ASCO 2024

GRAIL Update on the Accelerated Implementation of Multi-Cancer Early Detection Technology by NHS England

April 2024 Business Update

Assessing Accelerated Implementation of Multi-Cancer Early Detection Technology in England to Help Address the Ever-Increasing Burden of Cancer

February 2024 Business Update

Reflections on 2023

GRAIL Statement on Divestiture

GRAIL Public Comments to FDA Advisory Committee on MCD Tests

New Study Confirms Cancer Found in Early Stages More Likely to be Cured

GRAIL Receives ISO 13485 Certification

November 2023 Business Update

GRAIL Named on Fortune’s Change the World List

An Assault On Cancer Screening Will Not Win The War on Cancer

July 2023 Business Update

Multi-Cancer Early Detection Requires a Rethink of Screening Clinical Trial Design

Progress Made on Decreasing Cancer Death Rates is Not Enough: A New Cancer Detection Paradigm is Needed

April 2023 Business Update

Shifting Cancer Detection and Treatment Earlier

Sir Harpal Kumar’s Keynote Address at WIRED UK

Reuters Events and GRAIL Publish Whitepaper on Multi-Cancer Early Detection Implementation in Health Systems

January 2023 Business Update

A Look Back at 2022

Galleri Named to TIME’s List of the Best Inventions of 2022

October 2022 Business Update

Maximizing Cancer Early Detection and Minimizing Harm

August 2022 Business Update

Cancer game-changer a step closer as thousands take part in trial | ITV News

GRAIL and Westminster Fire Department Partner to Offer Galleri® Multi-Cancer Early Detection Test to Firefighters

GRAIL Statement on The New York Times Multi-Cancer Early Detection Story

GRAIL Named “Best Overall Medical Device Company” in 2022 MedTech Breakthrough Awards

GRAIL’s Galleri Multi-Cancer Early Detection Test Named in Fast Company’s 2022 World Changing Ideas Awards List

April 2022 Business Update

New Blood Test Could Change the Way Cancer is Detected

12/20/2021 | NBC News

What to Know About Galleri, the New Blood Test Said to Detect More Than 50 Different Types of Cancer

11/08/2021 | Health.com

Catching cancer extremely early

03/26/2021 | Science Magazine

This New Blood Test Can Detect 50 Types of Cancers

03/17/2021 | Healthline

A New Early-Detection Blood Test Marks a Leap Forward in the War on Cancer

01/21/2021 | Fast Company

AJMC, Novel Multicancer Early Detection Technology—Potential Value to Employers and the Workforce

12/18/2020 | AJMC

A Novel Early Detection Blood Test Could Soon Change How Cancer is Found

The Guardian view on a new test for cancer: grounds for optimism

12/01/2020 | The Guardian

Taking Early Cancer Detection to the Next Level

11/01/2020 | Scientific American

Can a blood test detect cancer in asymptomatic patients?

10/28/2020 | CURE Magazine

The Cancer Detection Rate–a Public Health Approach to Early Detection

10/02/2020 | The Cancer Letter

Cancer Screening Leaps Forward

07/05/2020 | WSJ

Entering a New Era of Early Cancer Detection

Working to Transform Cancer Care Through Early Detection

Striving for Earlier Cancer Detection

Cancer Game-Changer a Step Closer as Thousands Take Part in Trial

08/01/2022 | ITV News

Contact us

1525 O’Brien Drive Menlo Park, CA 94025 | (833)-694-2553

Get in touch